News & Analysis as of

Science, Computers & Technology law-news Tax

Read Science, Computers & Technology updates, news, alerts, and legal analysis from leading lawyers and law firms:
Alston & Bird

‘Substantially Similar’ Regulatory Frameworks Under the GENIUS Act: Emerging State Legislation

Alston & Bird on

Our Financial Services Group examines state legislative actions that signal a growing state-level trend toward aligning regulatory frameworks for payment stablecoin issuers with GENIUS Act standards....more

Adler Pollock & Sheehan P.C.

AI, Patent Strategy, and What Actually Drives Outcomes in 2026 – Part 2

Part 1 of this series focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has dramatically improved efficiency, but strategic value increasingly comes from understanding where...more

Alston & Bird

Your AI Therapist May Need a Lawyer: Pennsylvania Brings Suit Against Chatbot Developer

Alston & Bird on

Our Health Care Group investigates a lawsuit against Character.AI that raises legal risks for AI platforms presenting themselves as licensed professionals and signals tightening regulatory scrutiny....more

Stikeman Elliott LLP

AI Use by Financial Institutions: Québec’s AMF Publishes Final Guidelines

Stikeman Elliott LLP on

Québec’s financial institutions regulator, the Autorité des marchés financiers (“AMF”), recently published (in French only) a final version of its guidelines (“Final Guidelines”) on the use of artificial intelligence systems...more

Friling Law

Semiconductor Export Controls in 2026: Dual-Use Risk, Re-export, Sanctions Exposure, and Compliance Strategy

Friling Law on

Semiconductors are among the most strategically sensitive products in global trade. In 2026, exporting semiconductors is no longer a routine commercial matter: it is a legal, geopolitical, and compliance issue involving...more

EDRM - Electronic Discovery Reference Model

Using AI for Legal Tasks: When Delegation Becomes a Dirty Word

As a trial lawyer, I had a problem with delegation. I realized then that I took more responsibility for early case assessment, building my case, discovery details, exhibit content, and presentation strategy than most of my...more

Maynard Nexsen

Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake...

Maynard Nexsen on

Hosts Heather and Lauren are joined by Leslie Isenhour, Dean of Biotechnologies and North Carolina BioNetwork Capstone Center at Wake Tech Community College. With the growing demand for life sciences talent in North Carolina,...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Intellectual Property as a Value Driver and Risk Factor in Life Sciences Venture Investment: A Ten-Issue Due Diligence Framework

For venture capital investors in the life sciences sector, intellectual property (IP) is not merely a legal checklist item, it can be a primary determinant of company value, competitive insulation, and exit options....more

Vedder

How AI is Changing The Game for Regulatory Reporting – And Why You Should Be Cautious

Vedder on

Artificial Intelligence (AI) is everywhere right now and as most businesses know, it’s about much more than creating memes or drafting school essays. AI can create significant efficiencies for companies dealing with large...more

Skadden, Arps, Slate, Meagher & Flom LLP

AI Act State of Play – Key Obligations Postponed and Amended, Alongside New Guidance

On 7 May 2026, the European Parliament (EP) and the European Council (Council) announced that they had reached an agreement to amend the EU’s AI Act....more

Offit Kurman

“Alright, Alright, Alright,” — Taylor’s Version. Taylor Swift follows Matthew McConnaughey’s Novel Approach to Using Trademark...

Offit Kurman on

Ever eager to retain control over her masters and ensure that she “never goes out of style,” Taylor Swift is the latest public figure looking toward registration of sensory trademarks to protect her name and likeness in a...more

Kelley Drye & Warren LLP

The Algorithm Ate My Residency (And Other Stories for Employers)

Employers using AI-powered tools to screen, rank, or normalize job applicants face significant and growing litigation risk—particularly when they cannot explain how algorithmic decisions are made....more

IMS Legal Strategies

Pitfalls to Avoid When Hiring Jury Consulting Firms

IMS Legal Strategies on

Engaging a jury consulting firm can materially shape the trajectory and outcome of your case. The right team brings not only insight into juror decision-making, but also discipline around strategy, sequencing, and execution....more

Health Care Compliance Association (HCCA)

Notice ‘Subtle’ Behavior, Fight Cynicism: Tips From Whistleblower Attorney in $15M Dana-Farber Case

The principal investigator (PI) looks away, perhaps bored, when the postdoc honestly describes an experiment that doesn’t work. In contrast, the PI smiles and invites students to dinner when they report something positive....more

FBT Gibbons LLP

When Your Vendor’s Breach Becomes Your Lawsuit: Privacy Risk Lessons from Recent Bank Litigation

FBT Gibbons LLP on

A recent high-profile incident illustrates the growing litigation and regulatory risks that financial institutions face from vendor-driven data breaches. Within weeks of a national bank confirming a data security incident at...more

Baker Botts L.L.P.

Colorado Pioneers First-in-Nation Ban on "Surveillance Pricing" and Algorithmic Wage Setting

Baker Botts L.L.P. on

As businesses increasingly rely on AI and algorithmic models to optimize pricing and labor costs, state legislatures are drawing strict boundaries around the data fueling these systems....more

Baker Botts L.L.P.

From "Paper Compliance" to "Technical Verification": The $12.75M GM Settlement and Beyond

Baker Botts L.L.P. on

The era of "checking the box" on privacy is over. California regulators have moved past simple policy audits and are now "pen-testing" the actual technical architecture of corporate data flows....more

Skadden, Arps, Slate, Meagher & Flom LLP

Report From FDLI Annual Meeting: FDA’s Expanding Use of AI – What Regulated Industry Should Know

The U.S. Food and Drug Administration (FDA) is rapidly incorporating artificial intelligence (AI) into nearly every dimension of its operations: from application review and inspectional planning to enforcement communications...more

McDermott Will & Schulte

Accelerating access, raising the bar: Key FDA developments over the past six months

Over the past six months, the US Food and Drug Administration (FDA) has pursued a dual regulatory agenda: expanding flexibility to accelerate development and access while sharpening expectations around evidence generation,...more

Fisher Phillips

Silicon Valley Snapshot on Looming Cybersecurity Reporting Rules: Top CIRCIA Takeaways for the Tech Industry

Fisher Phillips on

Many tech companies will soon need to comply with new cybersecurity reporting obligations as federal officials close in on finalizing a proposed rule that will carry out core goals of the Cyber Incident Reporting for Critical...more

WilmerHale

How AI Use Can Increase Failure to Prevent Fraud Risk

WilmerHale on

Companies increasingly rely on artificial intelligence (AI) to streamline workflows, improve efficiency, and perform complex tasks. To date, much commentary on AI risk has focused on external threats to companies (for...more

Fisher Phillips

Feds Target Tech Sector Immigration Practices: 5 Ways to Safeguard Your Hiring Process

Fisher Phillips on

The federal government is ramping up enforcement against tech companies that allegedly hire foreign nationals using temporary work visas, when qualified U.S. workers may be available. In a recently filed lawsuit against a...more

McNees Wallace & Nurick LLC

Legal update: Using AI for legal advice? Proceed with caution

Public AI chatbots may be convenient, but they are not a substitute for legal counsel. When someone is facing a lawsuit, government investigation, or other sensitive legal issue, it may be tempting to ask a chatbot for quick...more

Venable LLP

Spotlight On: Prolia® / Xgeva® (denosumab) / Jubbonti® / Wyost® (denosumab-bbdz) / Ospomyv® / Xbryk® (denosumab-dssb) / Stoboclo®...

Venable LLP on

Denosumab Challenged Claim Types in Litigation: Claims are counted in each litigation, so claims from the same patent challenged in multiple litigations are counted more than once. Within each litigation a claim is counted...more

Brooks Kushman P.C.

Foreign Filing Licenses in a Global Market

Brooks Kushman P.C. on

Innovation today rarely sits within a single building or even a single country. Multinational teams collaborate across borders, and ideas move faster than the rules designed to regulate them. Yet when it comes to patent...more

90,369 Results
 / 
View per page
Page: of 3,615

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide